Purchased 3,195 Class A ordinary shares in the April 2024 private placement at $3.13 per share
| Officer | Age | In this role | Joined | 2025 pay | Source |
|---|---|---|---|---|---|
|
Sandeep Kulkarni
Also a director
Chief Executive Officer and Director
|
44 | Not stated | Not stated | Not reported | |
|
Kim Davis
Chief Operating Officer, Chief Legal Officer and Corporate Secretary
|
58 |
Since 2025
1 year
|
2022 | $1,281,291 | |
|
Gary Whale
Chief Technology Officer
|
52 |
Since 2023
3 years
|
2023 | Not reported | |
|
Kiran Nistala
Chief Medical Officer and Head of Development
|
54 |
Since 2023
3 years
|
Not stated | $1,022,568 |
Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.
Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.
Purchased 3,195 Class A ordinary shares in the April 2024 private placement at $3.13 per share
Purchased 7,987 Class A ordinary shares in the April 2024 private placement at $3.13 per share
Purchased 159,744 Class A ordinary shares in the April 2024 private placement at $3.13 per share
Purchased 1,186,901 Class A ordinary shares in the April 2024 private placement at $3.13 per share
Purchased 1,000,000 Class A ordinary shares and 500,000 pre-funded warrants in the February 2026 public offering
Purchased 2,000,000 Class A ordinary shares in the February 2026 public offering
Purchased 3,500,000 Class A ordinary shares and 500,000 pre-funded warrants in the February 2026 public offering
Purchased 400,000 Class A ordinary shares and 2,500,000 pre-funded warrants in the February 2026 public offering
Surrendered 4,000,000 Class A ordinary shares for no consideration in exchange for pre-funded warrants to purchase 4,000,000 Class A ordinary shares
Agreed to surrender 3,500,000 Class A ordinary shares for no consideration in exchange for pre-funded warrants to purchase 3,500,000 Class A ordinary shares
Agreed to surrender 3,000,000 Class A ordinary shares for no consideration in exchange for pre-funded warrants to purchase 3,000,000 Class A ordinary shares
Employed by the Company as Senior Director, Corporate Planning & Operations, with compensation in 2024 and 2025
Letter agreement under which the Company issued 8,657,402 Class A ordinary shares, paid an upfront fee of $7.3 million, and agreed to a $25.0 million milestone payment and 2% Net Sales payments
Loading...